T 0801/10 (Use of aripiprazole/OTSUKA) of 8.7.2014

European Case Law Identifier: ECLI:EP:BA:2014:T080110.20140708
Date of decision: 08 July 2014
Case number: T 0801/10
Application number: 05023971.4
IPC class: A61K 31/496
A61K 45/06
A61P 25/18
A61P 25/28
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 486 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
Applicant name: OTSUKA PHARMACEUTICAL CO., LTD.
Opponent name: Teva Pharmaceutical Industries Ltd.
STADA Arzneimittel AG
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 100(b)
Rules of procedure of the Boards of Appeal Art 12(4)
Rules of procedure of the Boards of Appeal Art 13(1)
Keywords: Main, first auxiliary requests: lack of sufficiency of disclosure of purpose claimed
Catchwords:

-

Cited decisions:
T 0609/02
T 0433/05
T 0801/06
Citing decisions:
T 2059/13
T 1868/16

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t100801eu1.html

Date retrieved: 17 May 2021

6 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: II Conditions to be met by an Application

General Case Law